Citigroup Maintains Neutral on Cardinal Health, Raises Price Target to $90
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Daniel Grosslight maintains a Neutral rating on Cardinal Health (NYSE:CAH) and raises the price target from $88 to $90.
June 12, 2023 | 1:50 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Citigroup maintains a Neutral rating on Cardinal Health and raises the price target from $88 to $90.
Citigroup's decision to maintain a Neutral rating on Cardinal Health indicates that the analyst does not see significant upside or downside potential in the short term. However, the raised price target from $88 to $90 suggests a slightly more positive outlook on the stock. The impact on the stock price is expected to be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100